Effects of sitagliptin, acarbose and sulfonylureas on postprandial levels of GLP-1 and GIP in Japanese patients with type 2 diabetes

被引：0
|
作者：
Yabe, D. [1 ]
Watanabe, K. [1 ]
Sugawara, K. [1 ]
Kuwata, H. [1 ]
Kitamoto, Y. [1 ]
Sugizaki, K. [1 ]
Fujiwara, S. [1 ]
Hishizawa, M. [1 ]
Hyo, T. [1 ]
Kuwabara, K. [1 ]
Yokota, K. [1 ]
Iwasaki, M. [1 ]
Kitatani, N. [1 ]
Kurose, T. [1 ]
Seino, Y. [1 ]
机构：
[1] Kansai Elect Power Hosp, Div Diabet Clin Nutr & Endocrinol, Osaka, Japan
来源：
DIABETOLOGIA | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
838
引用
收藏
页码：S342 / S342
页数：1
相关论文
共 50 条
  • [1] The role of GLP-1 in the postprandial effects of acarbose in type 2 diabetes
    Dalsgaard, Niels B.
    Gasbjerg, Laerke S.
    Hansen, Laura S.
    Hansen, Nina L.
    Stensen, Signe
    Hartmann, Bolette
    Rehfeld, Jens F.
    Holst, Jens J.
    Vilsboll, Tina
    Knop, Filip K.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2021, 184 (03) : 383 - 394
  • [2] Metformin enhances secretion of GLP-1 but not GIP and improves postprandial glucose excursion in Japanese patients with type 2 diabetes
    Kuwata, H.
    Yabe, D.
    Sugawara, K.
    Usui, R.
    Sugizaki, K.
    Kitamoto, Y.
    Fujiwara, S.
    Watanabe, K.
    Hyo, T.
    Murakami, T.
    Yamaguchi, T.
    Shimizu, S.
    Eto, H.
    Kurose, T.
    Seino, Y.
    DIABETOLOGIA, 2012, 55 : S97 - S97
  • [3] Comparison of acarbose versus voglibose monotherapy on GLP-1 secretion and postprandial dyslipidemia in patients with type 2 diabetes
    Shima, Kosuke
    Usuda, Rika
    Ni, Yinhua
    Kaneko, Shuichi
    Takamura, Toshinari
    Ota, Tsuguhito
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S97 - S98
  • [4] GIP Does Not Potentiate the Antidiabetic Effects of GLP-1 in Hyperglycemic Patients With Type 2 Diabetes
    Mentis, Nikolaos
    Vardarli, Irfan
    Koethe, Lars D.
    Holst, Jens J.
    Deacon, Carolyn F.
    Theodorakis, Michael
    Meier, Juris J.
    Nauck, Michael A.
    DIABETES, 2011, 60 (04) : 1270 - 1276
  • [5] Effects of Fat Supplementation on Postprandial GIP, GLP-1, Ghrelin and IGFBP-1 Levels: A Pilot Study on Adolescents with Type 1 Diabetes
    Lodefalk, M.
    Carlsson-Skwirut, C.
    Holst, J. J.
    Aman, J.
    Bang, P.
    HORMONE RESEARCH IN PAEDIATRICS, 2010, 73 (05): : 355 - 362
  • [6] Preserved Postprandial GLP-1 and GIP Responses in Patients With Maturity Onset Diabetes of the Young
    Ostoft, Signe H.
    Bagger, Jonatan I.
    Hansen, Torben
    Pedersen, Oluf
    Holst, Jens J.
    Knop, Filip K.
    Vilsboll, Tina
    DIABETES, 2013, 62 : A521 - A521
  • [7] Preserved postprandial GLP-1 and GIP responses in patients with maturity onset diabetes of the young
    Bagger, J. I.
    Ostoft, S. H.
    Hansen, T.
    Pedersen, O.
    Holst, J. J.
    Knop, F. K.
    Vilsboll, T.
    DIABETOLOGIA, 2013, 56 : S152 - S152
  • [8] Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes
    Gautier, J. -F.
    Choukem, S. -P.
    Girard, J.
    DIABETES & METABOLISM, 2008, 34 : S65 - S72
  • [9] Biological actions of the incretins GIP and GLP-1 and therapeutic perspectives in patients with type 2 diabetes
    Gautier, JF
    Fetita, S
    Sobngwi, E
    Salaün-Martin, C
    DIABETES & METABOLISM, 2005, 31 (03) : 233 - 242
  • [10] Postprandial concentrations of intact and total GIP and GLP-1 in type 2 diabetic patients and healthy subjects.
    Vilsboll, T
    Krarup, T
    Deacon, C
    Madsbad, S
    Holst, JJ
    DIABETOLOGIA, 2000, 43 : A147 - A147
12345